Latest Options News

Neurizon Therapeutics has launched a A$24.2 million equity raise to fund the next phase of clinical trials for its lead drug NUZ-001 targeting ALS, supported by a global licensing deal and a flexible convertible note facility.

Neurizon Therapeutics has locked in a $44 million funding package to fully support its lead drug NUZ-001 in the HEALEY ALS Platform Trial, marking a critical step toward potential regulatory approval and broader neurodegenerative applications.

MRG Metals has raised $0.73 million through a placement to advance its rare earth and heavy mineral sands projects in Mozambique and South Africa, including a strategic acquisition and mining license progression.

MRG Metals has completed the acquisition of the Garies Rare Earth Project, a high-grade, magnet-rich rare earth asset in South Africa, significantly boosting its critical minerals portfolio. The deal positions MRG for rapid development with a clear pathway to early cashflow and complements its existing projects in Mozambique and the Adriano–Fotinho corridor.

OZZ Resources has entered a binding option agreement with Scorpion Minerals, offering an exclusive chance to acquire its key tenements for $2.6 million plus a gold production royalty. The deal awaits shareholder approval and hinges on several regulatory and operational conditions.

Invion Limited’s partner Hanlim Pharm, backed by South Korea’s government grant, has secured up to A$2 million in non-dilutive funding to advance preclinical studies of HL270 for oesophageal cancer, paving the way for human trials in Australia.

Nova Minerals Limited has successfully closed a $20 million underwritten public offering on NASDAQ, aiming to accelerate exploration and development at its Estelle Gold and Critical Minerals Project in Alaska.

Emmerson Resources and Pan African Resources have approved a $6.9 million exploration budget for the Tennant Creek Joint Venture in Q1 2026, marking the largest quarterly spend in over two decades. The program targets high-grade gold deposits with extensive drilling and geophysical surveys.

Adisyn Ltd has completed a strategic review, deciding to boost investment in its graphene-based semiconductor arm while exploring options to unlock value from its managed IT services business.

VRX Silica Limited has announced a strategic leadership transition with Tony Swiericzuk appointed as CEO, succeeding Bruce Maluish who will step down in 2026 but remain on the board. This move positions VRX to advance its Arrowsmith North silica sand project towards production.

Audalia Resources has completed a $540,000 placement by issuing 20 million shares, aiming to advance mining design and permits at its Medcalf Project while exploring further funding options.

Lithium Universe Limited has completed the second tranche of its share placement, raising $40,000 and issuing over 56 million listed options, as it pushes forward with lithium refinery projects in Québec and Texas.